SNCA and Parkinson disease: Similarly, with the detection of α-synuclein oligomers from the brains of PD patients, the involvement of α-synuclein in PD pathogenesis is well established [21–23]; however, its role in the disease process and its effects on critical cellular pathways which contribute to neuronal death remain unknown.